Beardsworth News
Most Popular Beardsworth Story
CRO opts for standards in EDC
Contract researcher Beardsworth has tapped OmniComm's TrialMaster EDC solution for use in a Phase II vaccine study. Investigators plan to enroll 340 subjects in the 3-year, 10-site study. The CRO Read more...
Latest Headlines
- November 28, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
